Company Data
Phio Pharmaceuticals Corp.
Ticker
PHIO
Current Price
$1.98 -2.46%
Market Cap
$11.3M
Price Target
Refer to Report
Volume
75.3K
52wk Range
$0.9657 - $9.79
Overview
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company’s pipeline products include PH-762, PH-804, PH-790, and others.